Versant Capital Management, Inc Adamis Pharmaceuticals Corp Transaction History

Versant Capital Management, Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 16, 2019	SELL	$1.26 - $2.23 $1,035 - $1,833	-822 Closed	0 $0
Q1 2019 Apr 23, 2019	BUY	$2.02 - $3.22 $1,658 - $2,643	821 Added 82100.0%	822 $1,000
Q1 2019 Apr 23, 2019	SELL	$2.02 - $3.22 $1,658 - $2,643	-821 Reduced 99.88%	1 $1,000
Q3 2018 Oct 15, 2018	SELL	$2.25 - $4.8 $7,357 - $15,696	-3,270 Reduced 79.91%	822 $2,000
Q2 2018 Jul 06, 2018	SELL	$3.2 - $4.7 $3,020 - $4,436	-944 Reduced 18.75%	4,092 $13,000
Q1 2018 Apr 19, 2018	SELL	$2.55 - $4.85 $864 - $1,644	-339 Reduced 6.31%	5,036 $17,000
Q4 2017 Apr 19, 2018	BUY	$3.5 - $5.65 $6,692 - $10,802	1,912 Added 55.21%	5,375 $23,000
Q3 2017 Apr 23, 2018	BUY	$4.5 - $5.65 $15,583 - $19,565	3,463	3,463 $18,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Versant Capital Management, Inc with notifications on news.